. Aerocrine ab (STO:AEROB) announced that its handheld corridor myelitis monitor, niox MINO®, has been registered for marketing and on the block inwards china. Aerocrine’s structure of measuring blowhole inflammation, using exhaled nitric oxide (no) tests, has therewith been incorporated into china’s public guidelines since chalicosis management. Tests for ventiduct inflammation have received a reimbursement system.